Teladoc Health, Inc. (TDOC) EBITDA Margin: 5.82%
Is Teladoc Health, Inc.’s EBITDA margin high or low?
Teladoc Health, Inc.'s EBITDA margin of 5.82% is 237% above its 5-year average of -4.25%, near the high end of its 5-year range (-32.40%–5.82%).
As of Tuesday, June 23, 2026. 65.11% above its 12-month average of 3.53%.
TDOC EBITDA Margin Chart
TDOC Average EBITDA Margin Chart
TDOC Current vs Average EBITDA Margin Chart
TDOC EBITDA Margin Metrics
EBITDA MARGIN
5.82%
EBITDA MARGIN AVG TTM
3.53%
EBITDA MARGIN AVG 3Y
2.10%
EBITDA MARGIN AVG 5Y
-4.25%
EBITDA MARGIN AVG 10Y
-14.04%
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+65.11%
CURRENT VS 3Y AVG
+176.48%
CURRENT VS 5Y AVG
+236.78%
CURRENT VS 10Y AVG
+141.45%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
TDOC Competitors' EBITDA Margin
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Teladoc Health, Inc. (TDOC) | $1.37B | 5.82% | 3.53% | 2.10% | -4.25% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.03B | -1.25% | -7.46% | -6.38% | 1.15% |
| Shoulder Innovations, Inc. (SI)vs › | $366.44M | -78.37% | -58.33% | -56.62% | -56.62% |
| TransMedics Group, Inc. (TMDX)vs › | $2.61B | 24.52% | 20.18% | 1.54% | -35.22% |
| 23andMe Holding Co. (ME)vs › | $15.31M | -82.07% | -107.48% | -97.90% | -86.99% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.48B | 7.60% | 6.80% | 0.29% | -7.92% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.60B | 48.39% | -17.53% | -54.94% | 28.49% |
| Oscar Health, Inc. (OSCR)vs › | $7.63B | -3.34% | -1.19% | -4.96% | -19.15% |
| Tempus AI, Inc. (TEM)vs › | $8.35B | -17.48% | -52.76% | -51.11% | -63.28% |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.75B | 10.23% | 12.29% | 18.59% | 20.64% |
Margin Comparison
Gross Margin
65.6%
EBITDA Margin
5.8%
Operating Margin
-7.6%
Net Margin
-6.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
- Removes effects of depreciation policies (D&A)
- Capital structure neutral (ignores interest)
- Tax neutral (ignores tax differences)
- Good proxy for operating cash generation
Teladoc Health, Inc. EBITDA Margin Formula & Definition
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Teladoc Health, Inc. EBITDA Margin FAQ
- What is the EBITDA margin for Teladoc Health, Inc. (TDOC)?
- The EBITDA margin for TDOC stock is 5.82%.
- Is Teladoc Health, Inc.'s EBITDA margin high or low?
- Teladoc Health, Inc.'s EBITDA margin of 5.82% is 237% above its 5-year average of -4.25%, near the high end of its 5-year range (-32.40%–5.82%).
- What is the TTM average EBITDA margin for Teladoc Health, Inc. (TDOC)?
- The TTM average EBITDA margin for TDOC stock is 3.53%.
- What is the 3Y average EBITDA margin for Teladoc Health, Inc. (TDOC)?
- The 3Y average EBITDA margin for TDOC stock is 2.10%.
- What is the 5Y average EBITDA margin for Teladoc Health, Inc. (TDOC)?
- The 5Y average EBITDA margin for TDOC stock is -4.25%.
- What is the 10Y average EBITDA margin for Teladoc Health, Inc. (TDOC)?
- The 10Y average EBITDA margin for TDOC stock is -14.04%.
Teladoc Health, Inc. EBITDA Margin History
| DATE | EBITDA MARGIN |
|---|---|
| 2025-12-31 | 5.82% |
| 2024-12-31 | 1.23% |
| 2023-12-31 | 1.68% |
| 2022-12-31 | -0.31% |
| 2021-12-31 | -1.55% |
| 2020-12-31 | -32.40% |
| 2019-12-31 | -6.30% |
| 2018-12-31 | -7.27% |
| 2017-12-31 | -18.48% |
| 2016-12-31 | -35.95% |
| 2015-12-31 | -60.92% |
| 2014-12-31 | -28.04% |
| 2013-12-31 | -24.69% |
Related Metrics
About Teladoc Health, Inc.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Charles Divita